Smoking-induced generation of oxidized phospholipids and the effect of deficiency of hydrolyzing enzyme for oxidatively modified phospholipids : role of the enzyme deficiency in carcinogenesis and vascular injury.
Smoking-induced generation of oxidized phospholipids and the effect of deficiency of hydrolyzing enzyme for oxidatively modified phospholipids : role of the enzyme deficiency in carcinogenesis and vascular injury.
批准号:
11670360
负责人:
SATOH Kei
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Platelet-activating factor (PAF) is a bioactive phospholipid that has agonistic activities towards many types of cells such as white blood cells, smooth muscle cells, and neuronal cells ; and it is implicated various pathological conditions. Oxidation of ether phospholipids results in the generation of derivatives with a sn-2 short chain residue, and such derivatives also acquire PAF-like bioactivities. PAF or PAD-like lipids are inactivated by PAF acetylhydrolase (PAF-AH), and a high level of activity is found in plasma. Plasma PAF-AH deficiency is due to a missense mutation in the gene (G994T) and its prevalence among a general Japanese population is reported to be about 4%. This mutation is also known to be a genetic risk factor of stroke or ischemic heart disease.In the present study, we first found that the prevalence of plasma PAF-AH deficiency is virtually the same between healthy habitual smokers and non-smokers. There was no significant difference in the prevalence of the mutant gene between the group of the subjects who have risk factors for vascular diseases such as hypertension, diabetes mellitus, or hyperlipidemia (risk factor group) as compared to the group without such risk factors (normal group). However, among the subjects with normal genotype, the risk factor group had higher PAF-AH activity than the normal group. Such a difference was not observed for the subjects with the heterozygous genotype. Secondly, we detected an aggregating activity in lipid extracts of plasma obtained shortly after smoking cigarettes, and such activity co-migrated with authentic PAF in thin-layer chromatography.We conclude that plasma PAF-AH is increased in various diseases, including chronic lifestyle diseases, as an adoptive mechanism and the deficiency of this enzyme may be associated with enhanced risk for the diseases.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
佐藤敬,吉田秀見,今泉忠淳: "分泌型PAFアセチルヒドロラーゼ欠損と疾患リスク"実験医学. 18・2. 203-207 (2000)
Takashi Sato、Hidemi Yoshida、Tadashi Imaizumi:“分泌性 PAF 乙酰水解酶缺乏和疾病风险”实验医学 18・2(2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamada Y,Yoshida H,Ichihara S,Imaizumi T,Satoh K,Yokota M: "Correlations between plasma platelet-activating factor acetylhydrolase (PAF・AH) activity and PAF・AH genotype.age, and atherosclerosis in a Japanese population"Atherosclerosis. 130・1. 209-216 (200
Yamada Y、Yoshida H、Ichihara S、Imaizumi T、Satoh K、Yokota M:“日本人群血浆血小板活化因子乙酰水解酶(PAF·AH)活性与 PAF·AH 基因型、年龄和动脉粥样硬化之间的相关性”。 130・1。209-216 (200
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Stanimirovic D, Satoh K: "Inflammatory mediators of cerebral endothelium : a role in ischemic brain inflammation"Brain Pathol. 10(1). 113-126 (2000)
Stanimirovic D、Satoh K:“脑内皮炎症介质:在缺血性脑炎症中的作用”Brain Pathol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Satoh K,Yoshida H,Imaizumi T: "A mutation in plasma platelet-activating factor acetylhydrolase (Val279Phe) is an independent genetic risk factor for stroke"J Stroke Cerebrovasc Dis. 9・1. 49-50 (2000)
Satoh K、Yoshida H、Imaizumi T:“血浆血小板激活因子乙酰水解酶(Val279Phe)的突变是中风的独立遗传危险因素”J Stroke Cerebrovasc Dis. 49-50(2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
佐藤敬,吉田秀見,今泉忠淳: "血清PAFアセチルヒドロラーゼ欠損症と気管支喘息"現代医療. 31・1. 271-274 (1999)
Takashi Sato、Hidemi Yoshida、Tadashi Imaizumi:“血清 PAF 乙酰水解酶缺乏症和支气管哮喘”现代医学 31・1 271-274(1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
海外基金